Empagliflozin reduces neointimal formation and vascular smooth muscle cell proliferation via the suppression of PDGF-related signaling https://www.biorxiv.org/content/10.1101/2023.08.14.553316v1?med=mas
Empagliflozin reduces neointimal formation and vascular smooth muscle cell proliferation via the suppression of PDGF-related signaling https://www.biorxiv.org/content/10.1101/2023.08.14.553316v1?med=mas